Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Lyon
Clinical trial register · France

Clinical Trials in Lyon, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9697 matching records held by the registry are in this view. Synced 26 Oct 2026, 03:20 UTC
9697
Studies in scope
all four open statuses
6025
Recruiting now
open to new participants
1033
Lead sponsors
across recruiting studies
Top sites
Lyon 51 Marseille 16 Bordeaux 15 Lille 12 Paris 10
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Hospices Civils de Lyon187 AstraZeneca60 Centre Leon Berard51 GCS Ramsay Santé pour l'Enseignement et la Recherche36 Hoffmann-La Roche35 Clear sponsor filter
Site location
Lyon51 Marseille16 Bordeaux15 Lille12 Paris10
All 50 locations
Target enrolment
to

Trials with a site in Lyon

51 of 9697 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
Centre Leon Berard
Phase 1
26
Lyon
2026-11
Not yet open
Biomarker Investigation for Early Gastric Cancer Detection
NCT07884669Gastro Oesophageal Cancer
Centre Leon Berard
Not applicable
100
Lyon
2026-11
Not yet open
Centre Leon Berard
Phase 1/2
50
Bourg-en-Bresse, Clermont-Ferrand, Grenoble, Lille, Lyon, Marseille, Saint-Priest-en-Jarez, Toulouse
2026-09
Not yet open
Centre Leon Berard
Not applicable
40
Lyon, Villefranche-sur-Saône
2026-07-30
Not yet open
Heterogeneity of Oral Carcinogenesis: From PrEneoplasia to Invasive Squamous Cell Carcinoma
NCT07579507Oral Squamous Cell Carcinomas, Oral Potentially Malignant Disorder
Centre Leon Berard
Not applicable
150
Lyon
2026-06
Not yet open
Centre Leon Berard
Not applicable
300
Lyon
2026-05-01
Not yet open
Centre Leon Berard
Not applicable
10
Lyon
2026-04-05
Not yet open
Centre Leon Berard
Not applicable
100
Lyon
2026-03
Not yet open
Centre Leon Berard
Observational
30
Lyon
2026-02
Recruiting
Lifestyle Intervention Among Participants of the French Colorectal Cancer Screening Program (LIFE-SCREEN)
NCT06827366Colorectal Cancer Screening, Colorectal Cancer Prevention, Colorectal Cancer
Centre Leon Berard
Not applicable
800
Lyon
2026-01-26
Recruiting
Centre Leon Berard
Not applicable
100
Bourgoin, Grenoble, Lyon, Saint-Etienne, Villefranche-sur-Saône
2026-01-21
Recruiting
Centre Leon Berard
Phase 3
132
Brest, Clermont-Ferrand, Lyon, Marseille, Paris, Poitiers
2025-12-08
Recruiting
Centre Leon Berard
Phase 1/2
70
Angers, Bordeaux, Bron, Lille, Lyon, Marseille, Paris, Toulouse
2025-11-04
Not yet open
Evaluation of Efficacy and Safety De-escalation Versus Standard Adjuvant Chemotherapy in Patients With Low Risk Localized Gastroesophageal Adenocarcinoma
NCT06933966Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma, Non Metastatic Disease
Centre Leon Berard
Phase 2
120
Lyon, Marseille, Paris
2025-09-01
Active, closed
Validation of a Questionnaire in the French Language for the Patient Experience in Radiotherapy
NCT07133594Validation RTEQ (RadioTherapy Experience Questionnaire) in French, Patients Requiring Radiotherapy
Centre Leon Berard
Not applicable
320
Lyon
2025-08-07
Not yet open
Centre Leon Berard
Not applicable
50
Lyon
2025-05-15
Recruiting
Preoperative Magnetic Tracking in Breast Surgery in France: French Medical-economic Study.
NCT06906601Breast Cancer, Medico-economic Impact, Breast Cancer Surgery
Centre Leon Berard
Observational
772
Lyon, Nancy, Pontoise, Reims, Rennes, Villejuif
2025-04-15
Recruiting
Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma
NCT06706401Oropharynx Cancer, Larynx Cancer, Hypopharynx Cancer, Primary Head and Neck Tumor
DrugsVesanoid·ATRA·Cetuximab·Cisplatin
Centre Leon Berard
Phase 3
460
Lyon, Vandœuvre-lès-Nancy, Villejuif, Angers, Lille, Nice, Paris, Reims
2025-02-20
Recruiting
Centre Leon Berard
Not applicable
236
Angers, Besançon, Bordeaux, Caen, Lille, Lyon, Nancy, Nice
2025-01-14
Recruiting
Centre Leon Berard
Observational
80
Lyon
2024-12-18
Recruiting
Centre Leon Berard
Not applicable
30
Lyon
2024-12-13
Recruiting
Centre Leon Berard
Not applicable
100
Angers, Bourg-en-Bresse, Dijon, Grenoble, Lyon, Marseille, Nice, Saint-Herblain
2024-11-15
Not yet open
Assessing the Ompact of Neutral Pelvic Positioning on Bone Repositioning Quality in Pelvic Radiotherapy Patients
NCT06687200Radiotherapy, Repositonning Pelvic, Neutral Pelvic Positioning
Centre Leon Berard
Not applicable
200
Lyon, Nancy, Rennes, Saint-Herblain
2024-11-15
Recruiting
R-GASTIM- Study of Gastric Cancer Operable
NCT07787052Gastric Cancers
Centre Leon Berard
Observational
60
Lyon
2024-09-30
Active, closed
Centre Leon Berard
Not applicable
240
Lyon, Montpellier, Paris, Saint-Cloud, Vandœuvre-lès-Nancy, Villejuif
2024-09-12
Recruiting
Centre Leon Berard
Phase 2
60
Lyon
2024-04-26
Recruiting
Centre Leon Berard
Not applicable
204
Épagny, Grenoble, Lyon, Montpellier, Saint-Etienne, Villefranche-sur-Saône
2024-01-19
Recruiting
Centre Leon Berard
Not applicable
166
Nantes, Lyon, Angers, Bordeaux, Chambray-lès-Tours, Clermont-Ferrand, Dijon, Lille
2023-08-03
Recruiting
PREventing Second Cancers With DOSTARlimab
NCT05855811Recurrent Cancer, Primary Cancer, Second Cancer
DrugDostarlimab
Centre Leon Berard
Phase 2
400
Caen, Clermont-Ferrand, Lyon, Toulouse, Villejuif
2023-07-26
Recruiting
GastrOesophageal Tumor, Immune Microenvionnment (GOTIM)
NCT05644431GastroEsophageal Cancer
Centre Leon Berard
Observational
50
Lyon
2023-07-19
Active, closed
Centre Leon Berard
Phase 2
57
Lyon, Nice, Paris, Strasbourg, Toulouse
2023-01-06
Recruiting
Centre Leon Berard
Not applicable
214
Lyon
2022-11-29
Recruiting
Centre Leon Berard
Phase 2
90
Besançon, Bordeaux, Caen, Clermont-Ferrand, Lille, Limoges, Lyon, Marseille
2022-09-06
Recruiting
Profiling Program of Advanced/Metastatic Pancreatic Cancer Patients
NCT05380414Metastatic Pancreatic Cancer, Advanced Pancreatic Cancer
Centre Leon Berard
Not applicable
750
Lyon
2022-07-01
Active, closed
HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue Sarcomas
NCT05180695Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma
DrugsSiremadlin·Pazopanib
Centre Leon Berard
Phase 1/2
47
Bordeaux, Lyon, Marseille, Toulouse, Villejuif
2022-04-15
Recruiting
Centre Leon Berard
Not applicable
30
Lyon
2022-02-14
Active, closed
Centre Leon Berard
Phase 2
58
Lyon, Bordeaux, Lille, Marseille, Nice, Poitiers, Reims, Rennes
2022-01-14
Recruiting
Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten)
NCT05009927Metastatic Gastrointestinal Stromal Tumor (GIST), C-KIT Mutation, Advanced Gastrointestinal Stromal Tumor (GIST)
DrugsGlivec·Imatinib
Centre Leon Berard
Phase 2
50
Besançon, Bordeaux, Limoges, Lyon, Marseille, Paris, Reims, Rennes
2022-01-03
Active, closed
Immunotherapy in MSI/dMMR Tumors in Perioperative Setting.
NCT04795661Localized Resectable Tumor, MSI/dMMR
DrugPembrolizumab
Centre Leon Berard
Phase 2
240
Amiens, Clermont-Ferrand, Dijon, Lille, Lyon, Marseille, Montpellier, Nice
2021-10-18
Recruiting
Centre Leon Berard
Phase 2
36
Besançon, Bordeaux, Dijon, Lille, Lyon, Marseille, Montpellier, Nantes
2021-07-21
Recruiting
Centre Leon Berard
Observational
160
Lyon
2021-07-01
Active, closed
A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.
NCT04671693Late Effects, Testicular Germ Cell Tumor Mixed, Non-Metastatic Breast Carcinoma, Soft Tissue Sarcoma, Adult, Stage IIC
Centre Leon Berard
Not applicable
500
Lyon
2020-12-24
Recruiting
Centre Leon Berard
Observational
300
Lyon
2020-09-01
Recruiting
Centre Leon Berard
Not applicable
168
Besançon, Bordeaux, Lille, Lyon, Marseille, Montpellier, Paris, Poitiers
2020-03-03
Recruiting
Centre Leon Berard
Phase 2
455
Angers, Bordeaux, Caen, Lyon, Marseille, Nice, Paris, Rouen
2020-01-28
Recruiting
Centre Leon Berard
Observational
400
Lyon
2019-05-02
Recruiting
Centre Leon Berard
Phase 2
40
Besançon, Bordeaux, Caen, Clermont-Ferrand, Lille, Limoges, Lyon, Marseille
2019-01-23
Active, closed
Centre Leon Berard
Phase 2
90
Avignon, Besançon, Clermont-Ferrand, Grenoble, Lyon, Pringy, Saint-Etienne, Sainte-Foy-lès-Lyon
2018-08-06
Active, closed
Centre Leon Berard
Phase 2
62
Bordeaux, Lille, Lyon, Toulouse, Villejuif
2018-08-01
Recruiting
LIquid BIopsies in Patients Presenting Non-small Cell Lung Cancer
NCT02511288Carcinoma, Non-Small-Cell Lung
Centre Leon Berard
Observational
900
Annecy, Bourg-en-Bresse, Bron, Grenoble, Lyon, Saint-Priest-en-Jarez, Villefranche-sur-Saône
2015-07
Recruiting
Centre Leon Berard
Phase 2
900
Bordeaux, Lyon, Marseille, Paris, Strasbourg, Toulouse
2014-03
Rows per page Showing 1–51 of 51
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 October 2026. https://priyalifescience.com/clinical-trials-france/city/lyon

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,697 studies in total at the last sync on 26 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 51 of those studies with a site in Lyon that also match the filters currently applied.

How many clinical trials are recruiting in Lyon?

30 of the 51 studies on this page are recruiting new participants as of the 26 Oct 2026, 03:20 UTC sync. A further 12 have not yet opened recruitment, 9 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Lyon), 51 studies
PhaseStudiesRecruitingShare
Not applicable221143.1%
Phase 214827.5%
Observational9817.6%
Phase 1/2315.9%
Phase 3223.9%
Phase 1102%

Most active sponsors

Lead sponsors with the most studies (Lyon)
Lead sponsorStudiesRecruiting
Centre Leon Berard5130
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.